Prospective validation of a model‐informed precision dosing tool for vancomycin in intensive care patients-Reference-Cited by-同舟云学术

Prospective validation of a model‐informed precision dosing tool for vancomycin in intensive care patients

Published:2020-06-05 Issue:12 Volume:86 Page:2497-2506
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Heine Rob¹^ORCID,Keizer Ron J.²,Steeg Krista³,Smolders Elise J.⁴,Luin Matthijs⁵,Derijks Hieronymus J.⁶,Jager Cornelis P.C.⁷,Frenzel Tim⁸,Brüggemann Roger¹^ORCID

Affiliation:

1. Radboud Institute for Health Sciences, Department of Pharmacy Radboud university medical center Nijmegen The Netherlands

2. Insight Rx San Francisco California USA

3. Department of Clinical Pharmacy Ziekenhuisgroep Twente Almelo The Netherlands

4. Department of Pharmacy, Isala Hospital, Zwolle, The Netherlands & Department of Pharmacy, Radboud University Medical Center Radboud Institute of Health Sciences Nijmegen The Netherlands

5. Department of Clinical Pharmacy Rijnstate Hospital Arnhem The Netherlands

6. Department of Pharmacy, Jeroen Bosch Hospital, ‘s‐Hertogenbosch, The Netherlands/Department of Pharmacy Radboud University Medical Centre Nijmegen The Netherlands

7. Department of Intensive Care Medicine Jeroen Bosch Hospital 's‐Hertogenbosch the Netherlands

8. Department of Intensive Care Medicine Radboud University Medical Center Nijmegen The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14360

Reference29 articles.

1. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

2. The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents

3. Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?

4. Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

5. Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing Parametric and Nonparametric Models for Model-Informed Precision Dosing: A Quality Improvement Effort in Vancomycin for Patients With Obesity;Therapeutic Drug Monitoring;2024-05-10

2. External Validation of Obese/Critically Ill Vancomycin Population Pharmacokinetic Models in Critically Ill Patients Who Are Obese;The Journal of Clinical Pharmacology;2023-11-08

3. Model-informed precision dosing in vancomycin treatment;Frontiers in Pharmacology;2023-10-09

4. Model‐informed precision dosing of vancomycin for rapid achievement of target area under the concentration‐time curve: A simulation study;Clinical and Translational Science;2023-09-22

5. Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot Study;European Journal of Drug Metabolism and Pharmacokinetics;2023-06-15